Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Loading...
Community
/
Italy
/
Healthcare
/
Amplifon
AMP
Amplifon
Digital Disruption Will Squeeze Margins In Mature European Markets
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 15 Analysts
Published
24 Aug 25
Updated
24 Aug 25
1
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€15.95
1.1% undervalued
intrinsic discount
24 Aug
€15.78
1Y
-45.8%
7D
3.2%
Loading
1Y
-45.8%
7D
3.2%
Author's Valuation
€16.0
1.1% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€16.0
1.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
3b
2014
2017
2020
2023
2025
2026
2028
Revenue €2.7b
Earnings €205.5m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
5.74%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.83%
Calculation
€205.49m
Earnings '28
x
21.51x
PE Ratio '28
=
€4.42b
Market Cap '28
€4.42b
Market Cap '28
/
215.10m
No. shares '28
=
€20.55
Share Price '28
€20.55
Share Price '28
Discounted to 2025 @ 8.83% p.a.
=
€15.94
Fair Value '25